Sanofi-Aventis Deutschland

Type
Internal restructuring
Country
Germany
Region
Hessen; Darmstadt; Frankfurt am Main, Kreisfreie Stadt
Location of affected unit(s)
Frankfurt-Höchst
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.10 - Manufacture of basic pharmaceutical products
144 jobs
Number of planned job losses
Job loss
Announcement Date
19 June 2019
Employment effect (start)
19 June 2019
Foreseen end date
17 June 2020

Description

The French pharmaceutical manufacturer Sanofi confirmed that it will be cutting 144 jobs at its site in Frankfurt-Höchst as part of the restructuring programme ‘Horizon 2020’. However,  the company denied reports claiming that the job reduction will mainly affect the company’s diabetes research division. According to management, the job reduction will affect the entire plant in Frankfurt-Höchst with a maximum of 38 jobs in the diabetes research division affected. The company intends to emphasise on other ongoing projects.

Currently, Sanofi has 8,000 employees in Frankfurt-Höchst.

Sources

Citation

Eurofound (2019), Sanofi-Aventis Deutschland, Internal restructuring in Germany, factsheet number 98160, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/98160.